Related Experiment Video
Updated: Jun 3, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
Published on: January 25, 2019
Cardiac cell therapy: the next (re)generation
Elvira Forte1, Isotta Chimenti, Lucio Barile
1Department of Molecular Medicine, Pasteur Institute, Cenci-Bolognetti Foundation, University of Rome Sapienza, Rome, Italy.
Insights
Heart failure therapies aim to prevent disease progression. Regenerative medicine using stem cells shows promise for cardiac repair after myocardial infarction, but requires understanding basic mechanisms for improved outcomes.
Area of Science:
- Cardiovascular Research
- Regenerative Medicine
- Stem Cell Biology
Background:
- Heart failure is a leading cause of death globally.
- Current myocardial infarction treatments focus on limiting damage and improving function of remaining tissue.
- Cellular therapy offers a potential regenerative approach for lost cardiac tissue.
Purpose of the Study:
- To review the current state of cardiac regeneration research.
- To identify the need for understanding fundamental biological mechanisms in cardiac repair.
- To highlight strategies for enhancing cell-based therapies for heart failure.
Main Methods:
- Review of existing literature on cell types used in cardiac regeneration (bone marrow cells, myoblasts, stem cells, etc.).
- Analysis of outcomes from early clinical trials.
- Identification of key biological processes influencing therapeutic efficacy.
Main Results:
- Diverse cell types have been investigated for cardiac regeneration in preclinical models.
- Clinical trial results have been inconsistent, indicating a need for further research.
- Enhanced cellular homing, survival, and differentiation are critical for successful cell cardiomyoplasty.
Conclusions:
- A deeper understanding of cardiac regeneration mechanisms is essential.
- Optimizing cell behavior is key to improving cell-based therapies for heart failure.
- Future strategies should focus on enhancing the efficacy of cellular cardiomyoplasty.
Abstract:
Heart failure remains one of the main causes of morbidity and mortality in the Western world. Current therapies for myocardial infarction are mostly aimed at blocking the progression of the disease, preventing detrimental cardiac remodeling and potentiating the function of the surviving tissue. In the last decade, great interest has arisen from the possibility to regenerate lost tissue by using cells as a therapeutic tool. Different cell types have been tested in animal models, including bone marrow-derived cells, myoblasts, endogenous cardiac stem cells, embryonic cells and induced pluripotent stem cells. After the conflicting and often inconsistent results of the first clinical trials, a step backward needs to be performed, to understand the basic biological mechanisms underlying spontaneous and induced cardiac regeneration. Current studies aim at finding new strategies to enhance cellular homing, survival and differentiation in order to improve the overall outcome of cellular cardiomyoplasty.
Related Concept Videos
iPS Cell Differentiation
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture
Methods of Nuclear Reprogramming
Forced Transdifferentiation
Artificial transdifferentiation occurs...

